Welcome to episode 473 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in North America and Europe.

Today’s guest is Nikolaus Obholzer, Director of Computational Biology at Kronos Bio. Founded in 2017, Kronos Bio are a clinical-stage biopharmaceutical company dedicated to the discovery and development of therapeutics that target the dysregulated transcription that causes cancer and other serious diseases. Their team finds meaning in making purposeful connections as the company seeks to bring forward groundbreaking therapies for patients who need them.

Nikolaus is an experienced technical manager, thought leader and problem solver who likes to put scientific data to work and communicates the results to drive decisions. He is also a Computational Biologist with more than 15 years of drug discovery and biomedical research experience in vitro, in vivo and in silico. Nikolaus’ experience spans across academia, consulting, biotech and pharma.

In the episode, Nikolaus will talk about:

The interesting work Kronos Bio are doing in the Biotech space

How they are utilizing Machine Learning

His responsibilities and how the team has evolved

What the near future looks like for Kronos Bio

Why Kronos Bio is a great place to work

To find out more about all the great work happening at Kronos Bio, check out the website www.kronosbio.com and follow them on LinkedIn. You can also connect with Nikolaus directly on LinkedIn.

If you’re interested in exploring our latest Data Science &ML jobs, check out our live vacancies or upload your resume today to keep up to date with all the latest opportunities.

Subscribe to The Alldus Podcast: